Department of Medicine, division of Rheumatology, Maastricht University Medical Center, PO Box: 5800, 6202 AZ, Maastricht, The Netherlands.
Department of Rheumatology, Zuyderland Hospital, Henri Dunantstraat 5, 6419 PC, Heerlen, The Netherlands.
Clin Rheumatol. 2018 Sep;37(9):2367-2372. doi: 10.1007/s10067-018-4167-2. Epub 2018 Jun 9.
To explore in elderly patients with rheumatoid arthritis (RA) and comorbidity (1) in which order and why patients prioritize their morbidities with regard to functioning and health, (2) their beliefs about common (age-related) musculoskeletal complaints, and (3) experiences about the influence of comorbidity on medication treatment of RA. Patients between 50 and 85 years with RA and ≥ 1 comorbidity or lifestyle risk factor were invited for a semi-structured interview. Two readers coded the transcripts of the interviews, by using NVivo11 software. Fifteen patients (14 women; mean age 67 years (range 51-83 years); mean disease duration 14 years (range 1-39 years)) were interviewed. Only 3 (20%) out of 15 patients prioritized RA over their comorbidity; these patients often experienced severe functional limitations. The level of current or (perceived) future disability, risk of dependency, and the perceived lethality of a condition were considered by participants when prioritizing morbidities. Most participants had misconceptions about common age-related musculoskeletal complaints. Consequently, these participants attributed all joint complaints or even all physical complaints to RA, disregarding degenerative joint disease and physiological aging as alternative diagnoses. Half of the participants ever had to change RA medication because of comorbidity. Most of these patients had prioritized the comorbidity, sometimes even over treatment of RA disease activity. Most elderly RA patients with comorbidity prioritize the importance and treatment of comorbidity over RA. Better understanding of patients' beliefs on RA and comorbidity is essential when managing chronic conditions in elderly patients.
探讨患有类风湿关节炎(RA)和合并症的老年患者(1)他们在考虑功能和健康时,会按照什么顺序以及为什么会对各种疾病的严重程度进行优先排序;(2)他们对常见(与年龄相关的)肌肉骨骼疾病的看法;(3)以及他们对合并症对 RA 药物治疗影响的经验。邀请年龄在 50 至 85 岁之间、患有 RA 且合并症≥1 种或生活方式危险因素的患者进行半结构式访谈。两名读者使用 NVivo11 软件对访谈记录进行了编码。共对 15 名患者(14 名女性;平均年龄 67 岁(范围 51-83 岁);平均病程 14 年(范围 1-39 年))进行了访谈。在 15 名患者中,只有 3 名(20%)将 RA 置于合并症之上;这些患者通常经历严重的功能受限。参与者在对疾病严重程度进行排序时,考虑了当前或(预期)未来的残疾程度、依赖风险以及疾病的致死风险。大多数参与者对常见的与年龄相关的肌肉骨骼疾病存在误解。因此,这些参与者将所有关节疾病或甚至所有身体疾病都归因于 RA,而忽略了退行性关节疾病和生理性衰老等其他可能的诊断。一半的患者曾因合并症而不得不改变 RA 药物治疗。这些患者中大多数都将合并症的优先级放在了 RA 疾病活动的治疗之上。大多数患有合并症的老年 RA 患者都将合并症的重要性和治疗优先级放在 RA 之上。在管理老年患者的慢性疾病时,了解患者对 RA 和合并症的看法至关重要。